Siebert, S., Coates, L., Schett, G., Raychaudhuri, S., Chen, W., Gao, S., . . . Deodhar, A. (2024). Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley.
Чикаго-гийн эшлэл (17 дахь хэвлэлт)Siebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.
MLA -ийн эшлэл (9 дэх хэвлэлт)Siebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.
Анхааруулга: Эдгээр ишлэлүүд үргэлж 100% үнэн зөв биш байж магадгүй.